Organigram Global Inc.
corporate_fare Company Profile
Organigram Global Inc. (NASDAQ:OGI) is a publicly traded company in the Life Sciences sector. Wiseek monitors OGI SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Organigram Reports Sanity on Track, Canadian Market Share Leadership Ahead of Q3 Results
- Organigram Reports Steep Q2 Profitability Decline, $5.8M Impairment, and Revised FCF Guidance
- British American Tobacco Boosts Stake to 29.9% with C$105M Capital Infusion at Premium Pricing
- Organigram Closes Transformational Sanity Group Acquisition, Secures €40.3M BAT Private Placement & C$60M Credit Facilities
- Shareholders Approve Organigram's Acquisition of Sanity Group and Related Private Placement
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for OGI, detected from its recent SEC filings · based on capital-structure filings through 2026-02-19.
BAT Private Placement Secured · Significant Dilution
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
OGI files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.